The side effects that are known include nausea, vomiting, diarrhea, headache, dizziness, compaction in the gastrointestinal tract, and other GI-related symptoms like acid reflux, bloating, etc
Semaglutide is not recommended for people with type 1 Diabetes and Diabetic ketoacidosis
A meta-analysis summarizing epidemiological data on the effects of weight loss on cancer risk
The alternatives are: Wegovy (higher-dose semaglutide injection) Specifically approved for weight loss
Its improved resistance to degradation also supports studies requiring peptide stability over extended observation periods
Nasal sprays allow researchers to study absorption, receptor activation patterns, and peptide effectiveness without injectable delivery, making them useful in specific experimental models